SWA
GILD icon

Sax Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Sax Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Buy
2,588
+90
+4% +$11.9K 0.01% 411
2026
Q1 		$307K Sell
2,498
-238
-9% -$33.3K 0.01% 379
2025
Q4 		$336K Buy
2,736
+214
+8% +$26K 0.02% 371
2025
Q3 		$280K Buy
2,522
+69
+3% +$7.84K 0.02% 364
2025
Q2 		$272K Buy
2,453
+236
+11% +$25.1K 0.02% 358
2025
Q1 		$248K Buy
+2,217
New +$229K 0.02% 317

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Sax Wealth Advisors's GILD Position: Q2 2026 in Review

Sax Wealth Advisors increased its Gilead Sciences (GILD) stake by 3.6% in Q2 2026, buying an estimated $11.9K and bringing the position to 2,588 shares worth $361K. The position accounts for 0.01% of the portfolio, ranked #411.

Sax Wealth Advisors first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. 534 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sax Wealth Advisors held 2,588 shares of Gilead Sciences worth $361K as of Q2 2026.
  • Sax Wealth Advisors bought 90 Gilead Sciences shares in Q2 2026, an estimated $11.9K.
  • Gilead Sciences made up 0.01% of Sax Wealth Advisors's portfolio in Q2 2026, its #411 holding.
  • Sax Wealth Advisors first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • 534 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sax Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.